1
|
Aksoyalp ZŞ, Temel A, Karpuz M. Pharmacological Innovations in Space: Challenges and Future Perspectives. Pharm Res 2024; 41:2095-2120. [PMID: 39532779 DOI: 10.1007/s11095-024-03788-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2024] [Accepted: 10/17/2024] [Indexed: 11/16/2024]
Abstract
PURPOSE Since the first human experience in space, the interest in space research and medicine to explore universe is growing day by day. The extreme space conditions mainly radiation and microgravity effects on human physiology, antimicrobial susceptibility, and efficacy, safety, and stability of drugs. Therefore, the aim of this review is to address the impact of extreme space conditions, mainly microgravity and radiation, on human physiology and highlights the need for future approaches by evaluating the effectiveness of strategies to prevent or mitigate health problems. METHODS Published papers and NASA technical documents were searched in Pubmed and Google Scholar databases using the keywords ''antimicrobial susceptibility or drug resistance or drug stability or innovations or pharmacokinetic or pharmacodynamics'' and ''radiation or microgravity or space environments or space medicine or space pharmacy'' to prepare this review. RESULTS In this review, the challenges regarding physiological effects and drug-related problems are examined through the evaluation of extreme conditions in space. Medications used in spaceflight are summarized, and the role of pharmacists specializing in space medicine is briefly explained. Last but not least, to overcome the aforementioned issues, novel approaches have been addressed, such as personalised treatments, development of space-resistant formulations and various microbial applications. CONCLUSIONS Further research in the space medicine is required to facilitate the safe and healthy travel of humans to the Moon, Mars and other extraterrestrial destinations. One bear in mind that space research will contribute not only to the exploration of the universe, but also to the advancement of health and technological discoveries on Earth.
Collapse
Affiliation(s)
- Zinnet Şevval Aksoyalp
- Department of Pharmacology, Faculty of Pharmacy, Izmir Katip Celebi University, 35620, Izmir, Türkiye
| | - Aybala Temel
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Izmir Katip Celebi University, 35620, Izmir, Türkiye
| | - Merve Karpuz
- Department of Radiopharmacy, Faculty of Pharmacy, Izmir Katip Celebi University, 35620, Izmir, Türkiye.
| |
Collapse
|
2
|
Shi M, McHugh KJ. Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Adv Drug Deliv Rev 2023; 199:114904. [PMID: 37263542 PMCID: PMC10526705 DOI: 10.1016/j.addr.2023.114904] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 05/18/2023] [Accepted: 05/24/2023] [Indexed: 06/03/2023]
Abstract
The global pharmaceutical market has recently shifted its focus from small molecule drugs to peptide, protein, and nucleic acid drugs, which now comprise a majority of the top-selling pharmaceutical products on the market. Although these biologics often offer improved drug specificity, new mechanisms of action, and/or enhanced efficacy, they also present new challenges, including an increased potential for degradation and a need for frequent administration via more invasive administration routes, which can limit patient access, patient adherence, and ultimately the clinical impact of these drugs. Controlled-release systems have the potential to mitigate these challenges by offering superior control over in vivo drug levels, localizing these drugs to tissues of interest (e.g., tumors), and reducing administration frequency. Unfortunately, adapting controlled-release devices to release biologics has proven difficult due to the poor stability of biologics. In this review, we summarize the current state of controlled-release peptides and proteins, discuss existing techniques used to stabilize these drugs through encapsulation, storage, and in vivo release, and provide perspective on the most promising opportunities for the clinical translation of controlled-release peptides and proteins.
Collapse
Affiliation(s)
- Miusi Shi
- Department of Bioengineering, Rice University, Houston, TX 77030, USA; The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, PR China
| | - Kevin J McHugh
- Department of Bioengineering, Rice University, Houston, TX 77030, USA; Department of Chemistry, Rice University, Houston, TX 77030, USA.
| |
Collapse
|
3
|
Aziz S, Raza MA, Noreen M, Iqbal MZ, Raza SM. Astropharmacy: Roles of Pharmacist in Space. Innov Pharm 2022; 13:10.24926/iip.v13i3.4956. [PMID: 36627911 PMCID: PMC9815863 DOI: 10.24926/iip.v13i3.4956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Since disease is a natural aspect of life, human deep space missions will largely depend on preventing disease, diagnosis, and treatment. Pharmaceuticals are used to identify, treat, prevent, or cure illnesses, but they are unstable on Earth and even more so in space. What if the pharmacist could prepare small quantities of medicines in space, on site, as needed? The alteration in pharmacokinetic and pharmacodynamic (PK-PD) and pharmacogenomics with flying and medications will need to be customised for each person individually and specifically at the point of need because of drug stability issues. We can't meet the expense of bringging everything we might need, so pharmacists must devise ways to manufacture medications in-situ and on-demand. With this skill, pharmacists would be able to fulfill the demand of any exploration mission that involved spaceflight with robust pharmaceuticals that would be stable enough to last the duration of the mission, comprehensive enough to treat all potential medical events, safe, and effective, notwithstanding the known PK-PD and pharmacogenetic alterations that take place during spaceflight. The purpose of this article was to review topics related with Astropharmacy. The topics include: the need of Astropharmacy in space, health-related problems caused by hostile space conditions, storage problems in space, methods to establish the stability and effectiveness of pharmaceutical products in space, and alteration in human physiology including PK-PD and pharmacogenomics and highlight the pharmacist's potential roles in the pharmacies orbiting the space.
Collapse
Affiliation(s)
- Shireen Aziz
- Faculty of Pharmacy, The University of Faisalabad, Punjab, Pakistan,School of Pharmacy, Zhengzhou University, Henan, China,Faculty of Pharmacy, University of Sargodha, Punjab, Pakistan
| | - Muhammad Ahmer Raza
- Faculty of Pharmacy, The University of Faisalabad, Punjab, Pakistan,Department of Pharmacy Practice, The University of Lahore, Punjab, Pakistan
| | - Misbah Noreen
- Faculty of Pharmacy, The University of Faisalabad, Punjab, Pakistan
| | | | - Shahid Masood Raza
- Faculty of Pharmacy, The University of Faisalabad, Punjab, Pakistan,School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China,Corresponding author: Shahid Masood Raza School of Pharmacy, Tongji Medical College Huazhong University of Science and Technology Hubei, China;
| |
Collapse
|
4
|
Stability of Antimicrobial Drug Molecules in Different Gravitational and Radiation Conditions in View of Applications during Outer Space Missions. Molecules 2021; 26:molecules26082221. [PMID: 33921448 PMCID: PMC8069917 DOI: 10.3390/molecules26082221] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2021] [Revised: 04/07/2021] [Accepted: 04/09/2021] [Indexed: 11/16/2022] Open
Abstract
The evolution of different antimicrobial drugs in terrestrial, microgravity and hypergravity conditions is presented within this review, in connection with their implementation during human space exploration. Drug stability is of utmost importance for applications in outer space. Instabilities may be radiation-induced or micro-/hypergravity produced. The antimicrobial agents used in space may have diminished effects not only due to the microgravity-induced weakened immune response of astronauts, but also due to the gravity and radiation-altered pathogens. In this context, the paper provides schemes and procedures to find reliable ways of fighting multiple drug resistance acquired by microorganisms. It shows that the role of multipurpose medicines modified at the molecular scale by optical methods in long-term space missions should be considered in more detail. Solutions to maintain drug stability, even in extreme environmental conditions, are also discussed, such as those that would be encountered during long-duration space exploratory missions. While the microgravity conditions may not be avoided in space, the suggested approaches deal with the radiation-induced modifications in humans, bacteria and medicines onboard, which may be fought by novel pharmaceutical formulation strategies along with radioprotective packaging and storage.
Collapse
|
5
|
Lee HJ, Lee SH, Lee JH, Kim Y, Seong KM, Jin YW, Min KJ. Role of Commensal Microbes in the γ-Ray Irradiation-Induced Physiological Changes in Drosophila melanogaster. Microorganisms 2020; 9:microorganisms9010031. [PMID: 33374132 PMCID: PMC7824294 DOI: 10.3390/microorganisms9010031] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/19/2020] [Accepted: 12/22/2020] [Indexed: 12/29/2022] Open
Abstract
Ionizing radiation induces biological/physiological changes and affects commensal microbes, but few studies have examined the relationship between the physiological changes induced by irradiation and commensal microbes. This study investigated the role of commensal microbes in the γ-ray irradiation-induced physiological changes in Drosophila melanogaster. The bacterial load was increased in 5 Gy irradiated flies, but irradiation decreased the number of operational taxonomic units. The mean lifespan of conventional flies showed no significant change by irradiation, whereas that of axenic flies was negatively correlated with the radiation dose. γ-Ray irradiation did not change the average number of eggs in both conventional and axenic flies. Locomotion of conventional flies was decreased after 5 Gy radiation exposure, whereas no significant change in locomotion activity was detected in axenic flies after irradiation. γ-Ray irradiation increased the generation of reactive oxygen species in both conventional and axenic flies, but the increase was higher in axenic flies. Similarly, the amounts of mitochondria were increased in irradiated axenic flies but not in conventional flies. These results suggest that axenic flies are more sensitive in their mitochondrial responses to radiation than conventional flies, and increased sensitivity leads to a reduced lifespan and other physiological changes in axenic flies.
Collapse
Affiliation(s)
- Hwa-Jin Lee
- Department of Biological Sciences, Inha University, Incheon 22212, Korea; (H.-J.L.); (S.-H.L.); (J.-H.L.)
| | - Shin-Hae Lee
- Department of Biological Sciences, Inha University, Incheon 22212, Korea; (H.-J.L.); (S.-H.L.); (J.-H.L.)
| | - Ji-Hyeon Lee
- Department of Biological Sciences, Inha University, Incheon 22212, Korea; (H.-J.L.); (S.-H.L.); (J.-H.L.)
| | - Yongjoong Kim
- Laboratory of Low Dose Risk Assessment, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea; (Y.K.); (K.M.S.); (Y.W.J.)
| | - Ki Moon Seong
- Laboratory of Low Dose Risk Assessment, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea; (Y.K.); (K.M.S.); (Y.W.J.)
| | - Young Woo Jin
- Laboratory of Low Dose Risk Assessment, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea; (Y.K.); (K.M.S.); (Y.W.J.)
| | - Kyung-Jin Min
- Department of Biological Sciences, Inha University, Incheon 22212, Korea; (H.-J.L.); (S.-H.L.); (J.-H.L.)
- Correspondence:
| |
Collapse
|
6
|
Ammendola M, Haponska M, Balik K, Modrakowska P, Matulewicz K, Kazmierski L, Lis A, Kozlowska J, Garcia-Valls R, Giamberini M, Bajek A, Tylkowski B. Stability and anti-proliferative properties of biologically active compounds extracted from Cistus L. after sterilization treatments. Sci Rep 2020; 10:6521. [PMID: 32300137 PMCID: PMC7162948 DOI: 10.1038/s41598-020-63444-3] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Accepted: 03/23/2020] [Indexed: 12/21/2022] Open
Abstract
The growing interest of oncologists in natural compounds such as polyphenols and flavonoids is encouraging the development of innovative and efficient carriers for the delivery of those drugs. This study examines carboxymethyl chitosan-based microcapsules created by spray drying as a method for delivering biologically active compounds isolated from the Cistus herb. Effects of sterilization and encapsulation on the polyphenol and flavonoid content of Cistus extract were investigated to optimize the production process. Furthermore, in vitro studies were carried out to examine the anticancer properties of sterilized polyphenols and flavonoids on glioblastoma cells isolated from oncological patients. Acquired results show high anticancer potential towards glioblastoma as well as low cytotoxicity towards non-cancer cell lines by the substances in question. Steam sterilization is shown to affect the content of biologically active compounds the least. We demonstrate that the investigated form of drug encapsulation is both efficient and potentially possible to scale up from the viewpoint of the pharmaceutical industry.
Collapse
Affiliation(s)
- Mario Ammendola
- Departament d' enginyeria química, Universitat Rovira i Virgili, Av. dels Països Catalans 26, 43007, Tarragona, Spain
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Procter & Gamble Services Company n.v., Temselaan 100, 1853, Strombeek-Bever, Belgium
| | - Monika Haponska
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Eurecat, Centre Tecnològic de Catalunya, C/Marcellí Domingo s/n, 43007, Tarragona, Spain
| | - Karolina Balik
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Paulina Modrakowska
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Karolina Matulewicz
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Lukasz Kazmierski
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Aleksandra Lis
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Justyna Kozlowska
- Department of Chemistry of Biomaterials and Cosmetics, Faculty of Chemistry, Nicolas Copernicus University in Torun, Gagarina 7, 87-100, Torun, Poland
| | - Ricard Garcia-Valls
- Departament d' enginyeria química, Universitat Rovira i Virgili, Av. dels Països Catalans 26, 43007, Tarragona, Spain
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain
- Eurecat, Centre Tecnològic de Catalunya, C/Marcellí Domingo s/n, 43007, Tarragona, Spain
| | - Marta Giamberini
- Departament d' enginyeria química, Universitat Rovira i Virgili, Av. dels Països Catalans 26, 43007, Tarragona, Spain
| | - Anna Bajek
- Department of Tissue Engineering, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University in, Torun, Poland
| | - Bartosz Tylkowski
- Centre Tecnològic de la Química de Catalunya, Carrer Marcelli Domingo s/n, 43007, Tarragona, Spain.
- Eurecat, Centre Tecnològic de Catalunya, C/Marcellí Domingo s/n, 43007, Tarragona, Spain.
| |
Collapse
|
7
|
Johnson MM, Collier MA, Hoang KV, Pino EN, Gurysh EG, Gallovic MD, Zahid MSH, Chen N, Schlesinger LS, Gunn JS, Bachelder EM, Ainslie KM. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection. Mol Pharm 2018; 15:5336-5348. [PMID: 30296381 PMCID: PMC6330710 DOI: 10.1021/acs.molpharmaceut.8b00802] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Previously we have encapsulated host-directed therapy AR-12 into acetalated dextran (Ace-DEX) microparticles (MPs) to mitigate drug toxicity and passively target phagocytic host cells. Herein, we have improved upon our initial emulsion-based formulation of Ace-DEX MPs encapsulating AR-12 (AR-12/MPs) by improving the drug encapsulation efficiency, evaluating sterilization processes for manufacturing, and understanding cellular and in vivo trafficking of the MPs. By using an alternative solvent system, ethyl acetate, we report an increased encapsulation efficiency of AR-12 while maintaining the pH-responsive degradation kinetics of Ace-DEX MPs. To better manufacture this novel antimicrobial formulation, we sterilized AR-12/MPs by gamma irradiation or ethylene oxide and evaluated their efficacy against intracellular Salmonella enterica serovar Typhi. Sterilized AR-12/MPs resulted in a significant reduction in intracellular bacterial burden compared to Blank/MPs. We also characterized intracellular trafficking of Ace-DEX MPs encapsulating fluorophores, which demonstrated internalization of MPs in endo/lysosomal compartments and time and degradation-rate dependent lysosomal escape into cytosolic compartments. Additionally, in vivo toxicity was mitigated following encapsulation of AR-12, where the maximum tolerated dose of AR-12 was increased compared to soluble treatment via intranasal, intravenous, and intraperitoneal administration routes. Following in vivo trafficking of Ace-DEX MPs via the same routes, intranasal administration demonstrated the highest accumulation in the lungs, liver, and kidneys, which persisted out to 240 h. Overall, we have advanced the formulation of this host-directed therapy and broadened the understanding of Ace-DEX MP delivery.
Collapse
Affiliation(s)
- Monica M. Johnson
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Michael A. Collier
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Ky V. Hoang
- Texas Biomedical Research Institute, San Antonio, TX 78227, USA
| | - Erica N. Pino
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Elizabeth G. Gurysh
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Matthew D. Gallovic
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Md. Shamim Hasan Zahid
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Naihan Chen
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | | | - John S. Gunn
- Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA
| | - Eric M. Bachelder
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| | - Kristy M. Ainslie
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
- Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA
| |
Collapse
|
8
|
Galante R, Pinto TJA, Colaço R, Serro AP. Sterilization of hydrogels for biomedical applications: A review. J Biomed Mater Res B Appl Biomater 2017; 106:2472-2492. [PMID: 29247599 DOI: 10.1002/jbm.b.34048] [Citation(s) in RCA: 98] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2017] [Revised: 11/04/2017] [Accepted: 11/12/2017] [Indexed: 12/19/2022]
Abstract
Despite the beneficial properties and outstanding potential of hydrogels for biomedical applications, several unmet challenges must be overcome, especially regarding to their known sensitivity to conventional sterilization methods. It is crucial for any biomaterial to withstand an efficient sterilization to obtain approval from regulatory organizations and to safely proceed to clinical trials. Sterility assurance minimizes the incidence of medical device-related infections, which still constitute a major concern in health care. In this review, we provide a detailed and comprehensive description of the published work from the past decade regarding the effects of sterilization on different types of hydrogels for biomedical applications. Advances in hydrogel production methods with simultaneous sterilization are also reported. Terminal sterilization methods can induce negative or positive effects on several material properties (e.g., aspect, size, color, chemical structure, mechanical integrity, and biocompatibility). Due to the complexity of factors involved (e.g., material properties, drug stability, sterilization conditions, and parameters), it is important to note the virtual impossibility of predicting the outcome of sterilization methods to determine a set of universal rules. Each system requires case-by-case testing to select the most suitable, effective method that allows for the main properties to remain unaltered. The impact of sterilization methods on the intrinsic properties of these systems is understudied, and further research is needed. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2472-2492, 2018.
Collapse
Affiliation(s)
- Raquel Galante
- Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Butantã, São Paulo, Brazil.,Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal
| | - Terezinha J A Pinto
- Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Butantã, São Paulo, Brazil
| | - Rogério Colaço
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.,Departamento de Engenharia Mecânica and IDMEC, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal
| | - Ana Paula Serro
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.,Centro de Investigação Interdisciplinar Egas Moniz, Instituto Superior de Ciências da Saúde Egas Moniz, Quinta da Granja, Monte de Caparica, Caparica, Portugal
| |
Collapse
|
9
|
Naguib SS, Hathout RM, Mansour S. Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug. Drug Deliv 2017; 24:99-108. [PMID: 28155540 PMCID: PMC8248826 DOI: 10.1080/10717544.2016.1233588] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Usually the topical delivery of ocular drugs poses a great challenge. Accordingly, the work in this study comprised the use of different hybrids of generally regarded as safe (GRAS) oils and surfactants in order to develop and optimize novel acetazolamide (AZD) entrapped-vesicular systems aiming at improving its ocular delivery and reaching better therapeutic outcomes in the treatment of glaucoma. The phospholipid/cholesterol bilayer of the vesicles was enriched with hybrids of Tween 80, Labrasol, Transcutol and Labrafac lipophile WL in different masses and proportions according to a mixture design viz. D-optimal mixture design. Three models were generated comprising three responses: particles size, percentage of entrapment efficiency and amount of drug released after 24 hours (Q24h). The results demonstrated the ability of the penetration enhancing hybrids in modulating the three responses compared to the conventional liposomes. Transmission electron microscope was used to characterize the selected formulations. Sterilization of selected formulations was carried out using gamma radiation and the effect of gamma radiations on entrapment, particle size and in vitro release were studied. The selected sterilized formulations were tested in-vivo on the eyes of albino rabbits in order to evaluate the efficiency of the novel delivery systems on the intra-ocular pressure reduction (IOP) compared to drug solution and the conventional liposomes. The novel formulations proved their efficiency in reducing the IOP to lower values compared to the conventional liposomes, which pose new successful platform for ocular delivery of AZD and other anti-glaucoma drug analogs.
Collapse
Affiliation(s)
- Sarah S Naguib
- a Department of Pharmaceutical Technology , Faculty of Pharmacy and Biotechnology, German University in Cairo , Cairo , Egypt and
| | - Rania M Hathout
- a Department of Pharmaceutical Technology , Faculty of Pharmacy and Biotechnology, German University in Cairo , Cairo , Egypt and.,b Department of Pharmaceutics and Industrial Pharmacy , Faculty of Pharmacy, Ain Shams University , Cairo , Egypt
| | - Samar Mansour
- a Department of Pharmaceutical Technology , Faculty of Pharmacy and Biotechnology, German University in Cairo , Cairo , Egypt and.,b Department of Pharmaceutics and Industrial Pharmacy , Faculty of Pharmacy, Ain Shams University , Cairo , Egypt
| |
Collapse
|
10
|
Margul DJ, Park J, Boehler RM, Smith DR, Johnson MA, McCreedy DA, He T, Ataliwala A, Kukushliev TV, Liang J, Sohrabi A, Goodman AG, Walthers CM, Shea LD, Seidlits SK. Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel bridges. Bioeng Transl Med 2016; 1:136-148. [PMID: 27981242 PMCID: PMC5125399 DOI: 10.1002/btm2.10018] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2016] [Revised: 06/24/2016] [Accepted: 07/01/2016] [Indexed: 12/25/2022] Open
Abstract
The spinal cord is unable to regenerate after injury largely due to growth‐inhibition by an inflammatory response to the injury that fails to resolve, resulting in secondary damage and cell death. An approach that prevents inhibition by attenuating the inflammatory response and promoting its resolution through the transition of macrophages to anti‐inflammatory phenotypes is essential for the creation of a growth permissive microenvironment. Viral gene delivery to induce the expression of anti‐inflammatory factors provides the potential to provide localized delivery to alter the host inflammatory response. Initially, we investigated the effect of the biomaterial and viral components of the delivery system to influence the extent of cell infiltration and the phenotype of these cells. Bridge implantation reduces antigen‐presenting cell infiltration at day 7, and lentivirus addition to the bridge induces a transient increase in neutrophils in the spinal cord at day 7 and macrophages at day 14. Delivery of a lentivirus encoding IL‐10, an anti‐inflammatory factor that inhibits immune cell activation and polarizes the macrophage population towards anti‐inflammatory phenotypes, reduced neutrophil infiltration at both day 7 and day 28. Though IL‐10 lentivirus did not affect macrophages number, it skewed the macrophage population toward an anti‐inflammatory M2 phenotype and altered macrophage morphology. Additionally, IL‐10 delivery resulted in improved motor function, suggesting reduced secondary damage and increased sparing. Taken together, these results indicate that localized expression of anti‐inflammatory factors, such as IL‐10, can modulate the inflammatory response following spinal cord injury, and may be a key component of a combinatorial approach that targets the multiple barriers to regeneration and functional recovery.
Collapse
Affiliation(s)
- Daniel J Margul
- Dept. of Biomedical Engineering Northwestern University Evanston IL, 48109; Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109
| | - Jonghyuck Park
- Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109
| | - Ryan M Boehler
- Dept. of Chemical and Biological Engineering Northwestern University Evanston IL, 48109
| | - Dominique R Smith
- Dept. of Biomedical Engineering Northwestern University Evanston IL, 48109; Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109
| | - Mitchell A Johnson
- Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109
| | - Dylan A McCreedy
- Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109; Dept. of Chemical and Biological Engineering Northwestern University Evanston IL, 48109
| | - Ting He
- Dept. of Chemical and Biological Engineering Northwestern University Evanston IL, 48109
| | - Aishani Ataliwala
- Dept. of Bioengineering University of California Los Angeles Los Angeles CA, 90095
| | - Todor V Kukushliev
- Dept. of Chemical and Biological Engineering Northwestern University Evanston IL, 48109
| | - Jesse Liang
- Dept. of Bioengineering University of California Los Angeles Los Angeles CA, 90095
| | - Alireza Sohrabi
- Dept. of Bioengineering University of California Los Angeles Los Angeles CA, 90095
| | - Ashley G Goodman
- Dept. of Chemical and Biological Engineering Northwestern University Evanston IL, 48109
| | | | - Lonnie D Shea
- Dept. of Biomedical Engineering University of Michigan Ann Arbor MI, 48109; Dept. of Chemical Engineering University of Michigan Ann Arbor MI, 48109
| | - Stephanie K Seidlits
- Dept. of Chemical and Biological Engineering Northwestern University EvanstonIL, 48109; Dept. of Bioengineering University of California Los Angeles Los Angeles CA, 90095; Brain Research Institute University of California Los Angeles Los Angeles CA, 90095; Jonsson Comprehensive Cancer Center University of California Los Angeles Los Angeles CA, 90024
| |
Collapse
|